Exciting News from Pharmidex! | Pharmidex
October 23, 2024

We’re pleased to share that Ash Alavijeh, our Operations Manager, will be attending the 2nd Swiss Translational Medicine Conference in Bern on October 24th.

Ash will be delighted to meet fellow attendees, share insights, and explore potential collaborations. Don’t hesitate to reach out and have a chat!
Learn more about the event:
https://sitem-insel.ch/en/landingpages/2stmc


Looking forward to connecting with you all!

Swiss Translational Medicine

#Pharmidex #SwissTranslationalMedicineConference #DrugDiscovery #Pharma #PreclinicalResearch #Collaboration #2stmc at @sitem-insel. 🚀 #translationalmedicine #oncology #innovation #siteminsel

June 23, 2026
🏃‍♂️☀️ Congratulations to our Pharmidex team members who took part in the St Albans Summer Solstice 10K #BeatTheSunset ! It was great to see colleagues enjoying a fantastic summer evening while supporting their physical and mental wellbeing. At Pharmidex , we believe health extends beyond the laboratory and activities like these are a great way to stay active, connect with colleagues and have fun. Well done to everyone who took part and represented Pharmidex so positively!
June 19, 2026
A big thank you to our interns from City St George’s, University of London and heir fantastic contribution to Pharmidex over the past few months. They have supported scientific projects across the business, developed valuable technical skills and gained hands-on experience within a CRO environment. Their contribution has extended beyond the laboratory, helping with our website, marketing materials, conference preparation and business development activities. Science drives success, but communicating that science effectively is just as important. Our interns have helped us do both. Thank you for your hard work, enthusiasm, and dedication. We wish you every success in the next stage of your careers.
June 17, 2026
On 18 June, our COO, Ash Alavijeh , will join an industry panel discussing: "What are the advantages and disadvantages of working with UK-based Discovery CROs?" The session will explore the value of UK CROs in supporting innovation, protecting IP, accessing scientific expertise and accelerating drug discovery programmes. 📅 18 June 2025 📍 Cambridge 🕒 Panel Session: 12:20–12:45 We look forward to connecting with colleagues, collaborators, and innovators from across the life sciences community.
More Posts